Open AccessPatients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin
Author(s) -
AARLI J. A.,
STEFANSSON K.,
MARTON L. S. G.,
WOLLMANN R. L.
Publication year - 1990
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.1990.tb05440.x
Subject(s) - myasthenia gravis , immunology , thymoma , autoantibody , medicine , titin , antibody , sarcomere , myocyte
SUMMARY Patients with myasthenia gravis (MG) and thymoma have in their sera antibodies which react with non‐receptor antigens from striated muscle. The purpose of this investigation was to characterize the antigen(s). Polypeptides in homogenates from rat skeletal muscle were separated by SDS‐PAGE and trans‐blotted to nitrocellulose. Sera from six patients with MG and thymoma stained a large (molecular weight >500 kD) polypeptide. while no staining was observed with sera from 20 non‐thymoma MG patients. Titin is one of the large (> 500 kD) polypeptides of striated muscle and the antibody containing MG sera have antibodies that bind to titin in a preparation of myofibrillary proteins from rabbit skeletal muscle. The staining pattern is identical to that obtained with antiserum to titin, showing that the antigen has the same electrophoretic mobility as titin. Antibodies from the sera of the patients with MG and thymoma, affinity‐purified on the large polypeptide, reacted with skeletal muscle sections in a cross‐striational pattern, near the A/I band junction but within the I band, corresponding to the localization of one of the epitopes of titin. Our findings therefore indicate that the muscle antibodies found in the sera from some MG patients with thymoma are directed against titin.